Send me real-time posts from this site at my email
Motley Fool

Have Investors Expected Too Much From CBD Stocks?

It wasn't all that long ago that many investors expected CBD stocks to soar after the U.S. legalized hemp. The reality is that shares of top CBD stocks such as Charlotte's Web Holdings (OTC: CWBHF) have tanked. Corinne Cardina, The Motley Fool's Bureau Chief of Healthcare and Cannabis, recently spoke with former Canopy Growth CEO Bruce Linton about the CBD market. In this Fool Live video, she and longtime Motley Fool contributor Keith Speights follow up on Linton's comments and address the issue of whether or not investors simply expected too much from CBD stocks.

Here's The Marijuana Stock You've Been Waiting For
A little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming.

Cannabis legalization is sweeping over North America – 11 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018.

And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution.

Because a game-changing deal just went down between the Ontario government and this powerhouse company...and you need to hear this story today if you have even considered investing in pot stocks.

Simply click here to get the full story now.

Learn more

Corinne Cardina: So to transition into getting into some stocks, let's talk about CBD a little bit more. Like Bruce said, the CBD song had been playing really loudly for the past few years. In December 2018, the Farm Bill was passed. Hemp became legal to grow in the US. Charlotte's Web -- that is a big name in CBD, and its stock is down about 76 percent in the past year. Keith, were investors just expecting too much from CBD and where do you think the future of hemp lies?
Keith Speights: On the CBD question. I don't think that investors were necessarily expecting too much, but I think it was easy to overlook the fact that the FDA has an awful lot of say in how CBD is used, and they still have not finalized the regulations on CBD.
I think everyone was excited about the passage of the 2018 Farm Bill. It did legalize hemp throughout the US and that did open the door. But the reality check there was that the FDA still needed to make its decisions on how to regulate this industry. Until that happens, companies like Charlotte's Web, I think are going to flounder.
Now, when -- I won't say if -- when the FDA does finalize those regulations. It could be a great catalyst for these stocks. It could be more middle of the road, but at least there will be some definitiveness to it; the question marks will hopefully go away. So I think the expectations of a big, booming CBD industry aren't unrealistic necessarily, but we still have to wait to see what the FDA is going to decide.
Corinne Cardina: As with anything, we can always trust the cannabis space to bring lots of uncertainty.

Corinne Cardina has no position in any of the stocks mentioned. Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Charlotte's Web. The Motley Fool has a disclosure policy.


Popular posts

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue